...
首页> 外文期刊>The journal of asthma >Safety and benefits of inhaled hypertonic saline following airway challenges with endotoxin and allergen in asthmatics
【24h】

Safety and benefits of inhaled hypertonic saline following airway challenges with endotoxin and allergen in asthmatics

机译:吸入高渗盐水在气道挑战与内毒素和哮喘过敏原后的安全性和益处

获取原文
获取原文并翻译 | 示例

摘要

Objective: To determine whether induced sputum (IS) with hypertonic saline inhalation is safe to use in asthmatics within 24 hours of two commonly used airway challenges, namely endotoxin and dust mite allergen, and to assess whether IS can enhance mucociliary clearance (MCC) rates in asthmatics. Methods: IS (three 7-minute inhalation periods of 3%, 4%, and 5% hypertonic saline) was employed before (N = 29) and within 24 hours of inhaled challenges with endotoxin (N = 13) and dust mite allergen (N = 12) in a cohort of mild to moderate asthmatics. Safety was assessed by lung function (Forced Expiratory Volume in 1 second; FEV1) and MCC was measured using a radiolabeled gamma scintigraphy method (Tcm99 sulfur colloid). IS was performed pre and post MCC. Results: No significant lung function decrement was observed before or after inhaled challenges with endotoxin or dust mite allergen. IS significantly enhanced MCC rates before and after inhaled endotoxin challenge. Conclusion: Based on a small cohort, IS is safe to use in mild to moderate asthmatics before and within 24 hours of inhaled challenges with endotoxin and dust mite allergen. Furthermore, IS has beneficial effects on host defense function in asthmatics by enhancing MCC rates. ? 2017 Taylor & Francis Group, LLC.
机译:目的:鉴定诱导痰(IS)的高渗盐水吸入是安全的两次常用气道挑战,即内毒素和粉尘过敏原的哮喘内的安全性安全,并评估是否可以增强粘液清除(MCC)率在哮喘中。方法:在(n = 29)之前(n = 29)采用(3%,4%和5%高渗盐水的3%,4%和5%高渗盐水),在内毒素(n = 13)和粉尘螨过敏原中的24小时内吸入挑战( n = 12)在轻度到中度哮喘的群组中。通过肺功能评估安全性(1秒内的强制呼气量; FEV1)和MCC使用放射性标记的γ闪烁法(TCM99硫胶体)测量。是在MCC上进行的预先和发布。结果:在吸入内毒素或粉尘螨过敏原之前或之后未观察到显着的肺功能递减。在吸入内毒素挑战之前和之后,显着提高了MCC率。结论:基于小群组,在与内毒素和粉尘螨过敏原中吸入挑战的24小时内,在轻度至中等哮喘中,是安全的。此外,通过提高MCC速率,对哮喘的主体防御功能具有有益的影响。还2017年泰勒&弗朗西斯集团,LLC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号